四环生物
(000518)
| 流通市值：37.78亿 | | | 总市值：37.78亿 |
| 流通股本：10.30亿 | | | 总股本：10.30亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 110,742,539.5 | 81,170,293.95 | 344,383,390.72 | 294,374,160.07 |
| 营业总成本 | 140,621,025.54 | 94,301,571.33 | 377,470,904.68 | 306,462,411.54 |
| 其他经营收益 | | | | |
| 营业利润 | -28,185,569.21 | -12,506,862.98 | -40,524,931.67 | -13,130,682.43 |
| 利润总额 | -28,214,384.15 | -12,506,862.98 | -40,924,440.42 | -14,077,534.34 |
| 净利润 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 | -13,495,557.26 |
| 每股收益 | | | | |
| 其他综合收益 | 0 | 0 | 0 | 0 |
| 综合收益总额 | -28,440,705.84 | -12,282,807.7 | -39,610,830.88 | -13,495,557.26 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 325,616,392.13 | 325,130,541.55 | 384,705,107.38 | 396,836,459.55 |
| 非流动资产: | | | | |
| 非流动资产合计 | 133,990,990.84 | 154,079,740.58 | 109,337,562.4 | 112,307,943.51 |
| 资产总计 | 459,607,382.97 | 479,210,282.13 | 494,042,669.78 | 509,144,403.06 |
| 流动负债: | | | | |
| 流动负债合计 | 100,422,232.14 | 103,227,516.54 | 106,070,532.99 | 89,216,477.89 |
| 非流动负债: | | | | |
| 非流动负债合计 | 28,263,109.15 | 28,902,825.77 | 28,609,389.27 | 34,449,904.03 |
| 负债合计 | 128,685,341.29 | 132,130,342.31 | 134,679,922.26 | 123,666,381.92 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 308,787,797.89 | 323,307,245.31 | 334,621,015.31 | 359,015,929.35 |
| 股东权益合计 | 330,922,041.68 | 347,079,939.82 | 359,362,747.52 | 385,478,021.14 |
| 负债和股东权益合计 | 459,607,382.97 | 479,210,282.13 | 494,042,669.78 | 509,144,403.06 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 68,618,350.46 | 32,107,834.92 | 305,527,032.73 | 254,497,038.8 |
| 经营活动现金流出小计 | 85,887,694.07 | 47,929,827.24 | 227,409,882.61 | 170,525,785.21 |
| 经营活动产生的现金流量净额 | -17,269,343.61 | -15,821,992.32 | 78,117,150.12 | 83,971,253.59 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 457,226.35 | 9,257.75 | 1,597,028.64 | 1,592,000 |
| 投资活动现金流出小计 | 3,350,140.97 | 1,027,206 | 3,595,542.39 | 3,213,538.42 |
| 投资活动产生的现金流量净额 | -2,892,914.62 | -1,017,948.25 | -1,998,513.75 | -1,621,538.42 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 10,000,000 | 10,000,000 | 50,000,000 | 40,000,000 |
| 筹资活动现金流出小计 | 8,899,044.83 | 8,232,014.43 | 54,386,209.1 | 54,197,661.13 |
| 筹资活动产生的现金流量净额 | 1,100,955.17 | 1,767,985.57 | -4,386,209.1 | -14,197,661.13 |
| 汇率变动对现金及现金等价物的影响 | -42,734.61 | -28,861.44 | -34,676.79 | -23,814.95 |
| 现金及现金等价物净增加额 | -19,104,037.67 | -15,100,816.44 | 71,697,750.48 | 68,128,239.09 |
| 期末现金及现金等价物余额 | 60,587,953.9 | 64,591,175.13 | 79,691,991.57 | 76,122,480.18 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -19,104,037.67 | - | 71,697,750.48 | - |